[Herpetic disease].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis; D004660:Encephalitis / Q000209:etiology; D005260:Female; D005831:Genital Diseases, Female / Q000209:etiology; D005832:Genital Diseases, Male / Q000209:etiology; D006560:Herpes Labialis; D006561:Herpes Simplex; D006566:Herpesviridae Infections; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007136:Immunoglobulins / Q000627:therapeutic use; D007372:Interferons; D007635:Keratitis, Dendritic; D008297:Male; D008587:Meningitis, Viral / Q000209:etiology; D008875:Middle Aged; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000209:etiology; D013280:Stomatitis / Q000209:etiology; D014765:Viral Vaccines / Q000627:therapeutic use
D000998:Antiviral Agents; D007136:Immunoglobulins; D014765:Viral Vaccines; D003561:Cytarabine; D007372:Interferons; D007065:Idoxuridine
La malattia erpetica.